The abstract is read at the publisher; the summary is JClub's.
Adipocyte-derived miR-30e-5p is upregulated in obese humans with coronary artery disease and in obese mice, and it targets endothelial SLC7A11 to worsen atherosclerosis.
- Why it matters: Obesity increases atherosclerotic risk, but the endocrine-like adipose-to-vessel communication linking miR-30e-5p to SLC7A11 in vascular endothelium was unclear.
- What they did: The study mined miRNA data and validated serum miR-30e-5p by RT-PCR in patients, then used bulk and single-nucleus RNA-seq, metabolomics, and in silico analyses plus EC-specific Slc7a11 knockout mice and miR-30e-5p gain/loss-of-function.
- The result: Serum exosome–mediated miR-30e-5p targeting of SLC7A11 dysregulated glutamate/cystine metabolism, impaired mitochondrial function, and increased atherosclerosis; SLC7A11 overexpression or miR-30e-5p antagonism reversed EC dysfunction, while miR-30e-5p or white adipose exosomes phenocopied it and miR-30e-5p antagomir or GW4869 reduced atherosclerosis in Apoe-/- and ob/ob mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.